Temasek Holdings Portfolio holdings
AUM
$25.8B
1-Year Return
43.86%
This Quarter Return
+13.51%
1 Year Return
+43.86%
3 Year Return
+113.28%
5 Year Return
+128.2%
10 Year Return
+403.09%
AUM
$15.5B
AUM Growth
+$2.1B
(+16%)
Cap. Flow
+$420M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
80.2%
Holding
61
New
21
Increased
4
Reduced
6
Closed
2
Top Buys
| 1 |
NFX
Newfield Exploration
NFX
|
$180M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
$158M |
| 3 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$111M |
| 4 |
Broadcom
AVGO
|
$87.6M |
| 5 |
KREF
KKR Real Estate Finance Trust
KREF
|
$52.4M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$235M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$95.5M |
| 3 |
Dell
DELL
|
$77.3M |
| 4 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
$72M |
| 5 |
Thermo Fisher Scientific
TMO
|
$19.5M |
Sector Composition
| 1 | Consumer Discretionary | 38.44% |
| 2 | Industrials | 25.96% |
| 3 | Healthcare | 11.91% |
| 4 | Communication Services | 6.21% |
| 5 | Materials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNET
26
VNET Group
VNET
$2.06B
| $54.1M | 0.35% |
10,778,004
| – | – |
|
|
KREF
27
KKR Real Estate Finance Trust
KREF
$640M
| $52.4M | 0.34% |
+2,439,024
| New | +$52.4M |
|
28
Illumina
ILMN
$15.5B
| $48.1M | 0.31% |
285,024
| – | – |
|
|
ATH
29
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $42.8M | 0.28% |
862,204
-1,450,490
| -63% | -$72M |
|
|
NETS
30
DELISTED
Netshoes (Cayman) Limited
NETS
| $39.4M | 0.25% |
+2,071,127
| New | +$39.4M |
|
31
Mastercard
MA
$538B
| $32.4M | 0.21% |
267,006
| – | – |
|
|
EMWP
32
DELISTED
Eros Media World PLC
EMWP
| $31.5M | 0.2% |
137,766
| – | – |
|
33
SPDR S&P Regional Banking ETF
KRE
$4.03B
| $28.3M | 0.18% |
+515,700
| New | +$28.3M |
|
|
JUNO
34
DELISTED
Juno Therapeutics, Inc.
JUNO
| $27.4M | 0.18% |
915,750
| – | – |
|
|
CELG
35
DELISTED
Celgene Corp
CELG
| $26.8M | 0.17% |
+206,187
| New | +$26.8M |
|
36
Amgen
AMGN
$151B
| $26.1M | 0.17% |
+151,310
| New | +$26.1M |
|
37
Biogen
BIIB
$20.5B
| $25.8M | 0.17% |
+95,226
| New | +$25.8M |
|
|
MON
38
DELISTED
Monsanto Co
MON
| $25.5M | 0.16% |
+215,534
| New | +$25.5M |
|
39
Incyte
INCY
$16.7B
| $25.3M | 0.16% |
+201,304
| New | +$25.3M |
|
40
ICICI Bank
IBN
$114B
| $25.2M | 0.16% |
2,808,987
-1
| -0% | -$9 |
|
41
Vertex Pharmaceuticals
VRTX
$102B
| $25M | 0.16% |
+194,199
| New | +$25M |
|
42
JPMorgan Chase
JPM
$835B
| $24.2M | 0.16% |
+264,337
| New | +$24.2M |
|
43
Bank of America
BAC
$375B
| $19.4M | 0.12% |
+798,123
| New | +$19.4M |
|
|
ONC
44
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
| $17.1M | 0.11% |
380,000
| – | – |
|
45
Wells Fargo
WFC
$262B
| $14.4M | 0.09% |
+260,364
| New | +$14.4M |
|
46
Intellia Therapeutics
NTLA
$1.25B
| $12.6M | 0.08% |
790,527
| – | – |
|
47
AC Immune
ACIU
$216M
| $11.8M | 0.08% |
1,337,500
| – | – |
|
|
AMRS
48
DELISTED
Amyris Inc.
AMRS
| $10.5M | 0.07% |
3,302,585
-152,629
| -4% | -$485K |
|
49
Morgan Stanley
MS
$240B
| $4.82M | 0.03% |
+108,260
| New | +$4.82M |
|
50
Goldman Sachs
GS
$227B
| $4.51M | 0.03% |
+20,337
| New | +$4.51M |
|